| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |